NEW YORK, May 31, 2023 /PRNewswire/ — The Klein Law Firm announces that it is investigating allegations that Reata Pharmaceuticals, Inc. (“Reata”) (NASDAQ: RETA) violated federal securities laws. CURRENT INVESTIGATION DETAILS: On May 10, 2023, Reata issued a press release announcing its…
Month: May 2023
TSE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 20, 2023 in the Class Action Filed on Behalf of Trinseo PLC Shareholders
NEW YORK, May 31, 2023 /PRNewswire/ — The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Trinseo PLC (NYSE: TSE) alleging that the Company violated federal securities laws. Class Period: May 3, 2021 to March 27, 2023 Lead Plaintiff…
VIRT ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 18, 2023 in the Class Action Filed on Behalf of Virtu Financial, Inc. Shareholders
NEW YORK, May 31, 2023 /PRNewswire/ — The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Virtu Financial, Inc. (NASDAQ: VIRT) alleging that the Company violated federal securities laws. Class Period: March 1, 2019 to April 28, 2023 Lead…
VTNR ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 12, 2023 in the Class Action Filed on Behalf of Vertex Energy, Inc. Shareholders
NEW YORK, May 31, 2023 /PRNewswire/ — The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Vertex Energy, Inc. (NASDAQ: VTNR) alleging that the Company violated federal securities laws. Class Period: April 1, 2022 to August 8, 2022 Lead…
LPSN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 23, 2023 in the Class Action Filed on Behalf of LivePerson, Inc. Shareholders
NEW YORK, May 31, 2023 /PRNewswire/ — The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of LivePerson, Inc. (NASDAQ: LPSN) alleging that the Company violated federal securities laws. Class Period: May 10, 2022 to March 16, 2023 Lead…
FRC ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 23, 2023 in the Class Action Filed on Behalf of First Republic Bank Shareholders
NEW YORK, May 31, 2023 /PRNewswire/ — The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of First Republic Bank (OTC Other: FRC) alleging that the Company violated federal securities laws. Class Period: January 14, 2021 to March 14, 2023…
FHN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 21, 2023 in the Class Action Filed on Behalf of First Horizon Corporation Shareholders
NEW YORK, May 31, 2023 /PRNewswire/ — The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of First Horizon Corporation (NYSE: FHN) alleging that the Company violated federal securities laws. Class Period: February 28, 2022 to May 3, 2023…
CRL ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 18, 2023 in the Class Action Filed on Behalf of Charles River Laboratories International, Inc. Shareholders
NEW YORK, May 31, 2023 /PRNewswire/ — The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Charles River Laboratories International, Inc. (NYSE: CRL) alleging that the Company violated federal securities laws. Class Period: May 5, 2020 to…
TCBI NEWS: The Klein Law Firm Initiates an Investigation Involving Possible Securities Fraud Violations by Officers of Texas Capital Bancshares, Inc.
NEW YORK, May 31, 2023 /PRNewswire/ — The Klein Law Firm announces that it is investigating allegations that Texas Capital Bancshares, Inc. (“Texas Capital”) (NASDAQ: TCBI) violated federal securities laws. CURRENT INVESTIGATION DETAILS:On March 29, 2021, shares of Texas Capital stock…
PHAT NEWS: The Klein Law Firm Initiates an Investigation Involving Possible Securities Fraud Violations by Officers of Phathom Pharmaceuticals, Inc.
NEW YORK, May 31, 2023 /PRNewswire/ — The Klein Law Firm announces that it is investigating allegations that Phathom Pharmaceuticals, Inc. (“Phathom”) (NASDAQ: PHAT) violated federal securities laws. CURRENT INVESTIGATION DETAILS:On August 2, 2022, before market hours, Phathom issued a…
